CNIH3
Protein cornichon homolog 3
Also known as: CNIH-3, CNIH3_HUMAN, FLJ38993
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TBE1
- Gene
- CNIH3
- Ensembl
- ENSG00000143786
- Chromosome
- 1
- Canonical length
- 160 aa
- Protein class
- Predicted membrane proteins, Transporters
OverviewNCBI Gene
Predicted to enable channel regulator activity and signaling receptor binding activity. Involved in regulation of AMPA receptor activity. Predicted to be located in dendritic shaft and postsynaptic membrane. Predicted to be part of AMPA glutamate receptor complex. Predicted to be active in dendrite and glutamatergic synapse. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
160 residues, UniProt reviewed canonical sequence.
>Q8TBE1|CNIH3
1 MAFTFAAFCY MLSLVLCAAL IFFAIWHIIA FDELRTDFKS PIDQCNPVHA RERLRNIERI
61 CFLLRKLVLP EYSIHSLFCI MFLCAQEWLT LGLNVPLLFY HFWRYFHCPA DSSELAYDPP
121 VVMNADTLSY CQKEAWCKLA FYLLSFFYYL YCMIYTLVSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CNIH3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 11 nTPM
- hippocampal formation: 10 nTPM
- pancreas: 7.4 nTPM
- amygdala: 6.9 nTPM
- hypothalamus: 5.3 nTPM
- basal ganglia: 5.2 nTPM
Single-cell type
- pituicytes/fscs: 118 nCPM
- late spermatids: 117 nCPM
- podocytes: 112 nCPM
- bergmann glia: 111 nCPM
- astrocytes: 109 nCPM
- ependymal cells: 108 nCPM
Immune cell
- NK-cell: 0.3 nTPM
- memory B-cell: 0.1 nTPM
- T-reg: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- hypothalamus: 25 nTPM
- hippocampal formation: 23 nTPM
- cerebral cortex: 22 nTPM
- basal ganglia: 12 nTPM
- medulla oblongata: 12 nTPM
- midbrain: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.85
- gnomAD missense Z
- 0.68
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- neurotransmitter receptor localization to postsynaptic specialization membrane
- regulation of AMPA receptor activity
- regulation of membrane potential
- synaptic transmission, glutamatergic
- vesicle-mediated transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CNIH3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CNIH3 as an antibody target. Whether an autoantibody or antibody against CNIH3 could matter depends on whether native CNIH3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CNIH3 is annotated at the cell surface, where native CNIH3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CNIH3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...